What is JPMorgan Chase & Co.'s earnings per share (EPS)?

JPMorgan Chase & Co. (JPM) reported diluted earnings per share of $20.02 for fiscal year 2025. This represents a 1.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

JPMorgan Chase & Co. (JPM) Financials

JPM

Trailing 12 months to June 30, 2026

Revenue $199.4B +13.5% YoY

Net Income $65.0B +15.0% YoY

EPS (Diluted) $23.35 +19.8% YoY

Operating Cash Flow -$162.5B -9.4% YoY

Market Cap $888.6B as of Oct 12, 2026

Price / Sales 4.5x on $199.4B revenue, trailing 12 months to June 30, 2026

Price / Earnings 13.7x on $65.0B net income, trailing 12 months to June 30, 2026

Price / Book 2.4x on $374.6B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the JPM SEC filings page.

JPMorgan Chase & Co. (JPM) reported $199.4B in revenue over the twelve months to Jun 30, 2026, up 13.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JPM FY2025 2026-10-03

JPMorgan's earnings remain substantial, but its expanding balance sheet and volatile cash-flow subtotal show a financing-driven business.

In FY2025, net income was $57.0B while operating cash flow was -$147.8B. For a bank, that gap points to lending and deposit movements driving the cash-flow subtotal more than accounting-profit conversion; the prior year's -$42.0B reinforces its volatility.

FY2025 revenue rose to $182.4B, yet net income eased to $57.0B, so additional scale did not produce higher total profit. Net margin was 31.2%, below 33.0% in FY2024, indicating profitability compression rather than uninterrupted operating leverage.

Total assets expanded 10.5% in FY2025 while equity grew 5.1%, leaving liabilities to fund the larger share of expansion. Debt-to-equity moved to 11.2x from 10.6x, confirming a more liability-heavy balance-sheet posture.

Financial Health Signals

Financial Health Score 51/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of JPMorgan Chase & Co.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

JPMorgan Chase & Co. earned a return on assets of 1.3% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is down from 1.5% the prior year. Earnings ranks banks on that return over three years, and JPMorgan Chase & Co. scores 80/100 among other banks.

Growth

JPMorgan Chase & Co. reported revenue of $182.4B in fiscal year 2025, against $177.6B in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and JPMorgan Chase & Co. scores 48/100 among other banks.

Capital

JPMorgan Chase & Co. funded 8.2% of its assets with shareholders' equity at the end of fiscal year 2025, holding $362.4B of equity against $4.4T of assets. Capital ranks banks on that cushion, and JPMorgan Chase & Co. scores 10/100 among other banks.

Efficiency

Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. JPMorgan Chase & Co. scores 85/100 on it among other banks.

Credit Quality

Credit Quality measures the money a bank set aside for loans it expects to go bad, against the size of the loan book it set that money aside for. JPMorgan Chase & Co. scores 9/100 on it among other banks.

Stability

JPMorgan Chase & Co. reported net income of $57.0B in fiscal year 2025, against $58.5B in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and JPMorgan Chase & Co. scores 74/100 among other banks.

Piotroski F-Score Partial

2/6

JPMorgan Chase & Co. passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

$2.59used

For every $1 of reported earnings, JPMorgan Chase & Co. used $2.59 of operating cash (-$147.8B OCF vs $57.0B net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$57.3B

YoY+27.7%

QoQ+15.1%

5Y CAGR+13.5%

10Y CAGR+8.9%

JPMorgan Chase & Co. generated $57.3B in revenue in Q2 2026. This represents an increase of 27.7% from the same quarter a year earlier. Against the prior quarter it is up 15.1%.

Net Income

$21.2B

YoY+41.2%

QoQ+28.3%

5Y CAGR+12.1%

10Y CAGR+13.1%

JPMorgan Chase & Co. reported $21.2B in net income in Q2 2026. This represents an increase of 41.2% from the same quarter a year earlier. Against the prior quarter it is up 28.3%.

EPS (Diluted)

$7.70

YoY+46.9%

QoQ+29.6%

5Y CAGR+15.3%

10Y CAGR+17.4%

JPMorgan Chase & Co. earned $7.70 per diluted share (EPS) in Q2 2026. This represents an increase of 46.9% from the same quarter a year earlier. Against the prior quarter it is up 29.6%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$309.8B

YoY-26.3%

QoQ-0.7%

5Y CAGR-15.2%

JPMorgan Chase & Co. held $309.8B in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$1.50

YoY+7.1%

QoQ0.0%

5Y CAGR+10.8%

10Y CAGR+12.1%

JPMorgan Chase & Co. paid $1.50 per share in dividends in Q2 2026. This represents an increase of 7.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

2.66B

YoY-3.3%

QoQ-0.8%

5Y CAGR-2.3%

10Y CAGR-3.0%

JPMorgan Chase & Co. had 2.66B shares outstanding in Q2 2026. This represents a decrease of 3.3% from the same quarter a year earlier. Against the prior quarter it is down 0.8%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Net Margin

36.9%

YoY+3.5pp

QoQ+3.8pp

5Y change-2.3pp

10Y change+11.5pp

JPMorgan Chase & Co.'s net profit margin was 36.9% in Q2 2026, showing the share of revenue converted to profit. This is up 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Return on Equity

5.7%

YoY+1.4pp

QoQ+1.1pp

5Y change+1.5pp

10Y change+3.2pp

JPMorgan Chase & Co.'s ROE was 5.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$6.8B

YoY-9.6%

QoQ-18.5%

5Y CAGR+1.8%

JPMorgan Chase & Co. spent $6.8B on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 9.6% from the same quarter a year earlier. Against the prior quarter it is down 18.5%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

JPM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JPM quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$199.4B	$182.4B+2.8%	$177.6B+12.3%	$158.1B+22.9%	$128.7B+5.8%	$121.6B+1.4%	$120.0B+3.7%	$115.7B+6.4%	$108.8B+8.0%	$100.7B+4.3%	$96.6B+3.2%	$93.5B-1.6%	$95.1B-2.3%	$97.4B+0.3%	$97.0B-0.2%	$97.2B
SG&A Expenses	$57.2B	$54.5B+6.1%	$51.4B+10.5%	$46.5B+11.6%	$41.6B+8.0%	$38.6B+10.2%	$35.0B+2.4%	$34.2B+3.1%	$33.1B+6.1%	$31.2B+3.3%	$30.2B+1.5%	$29.8B-1.4%	$30.2B-2.1%	$30.8B+0.7%	$30.6B+5.3%	$29.0B
Interest Expense	$98.2B	$97.9B-3.4%	$101.3B+24.6%	$81.3B+211.6%	$26.1B+370.0%	$5.6B-44.2%	$10.0B-62.8%	$26.8B+27.3%	$21.0B+51.7%	$13.9B+41.3%	$9.8B+31.6%	$7.5B-5.5%	$7.9B-15.5%	$9.3B-15.3%	$11.0B-18.8%	$13.6B
Income Tax	$18.8B	$15.5B-6.4%	$16.6B+37.7%	$12.1B+42.0%	$8.5B-24.4%	$11.2B+68.0%	$6.7B-20.8%	$8.4B+1.7%	$8.3B-27.7%	$11.5B+16.9%	$9.8B+56.6%	$6.3B-30.1%	$9.0B+1.9%	$8.8B+15.1%	$7.6B-1.8%	$7.8B
Net Income	$65.0B	$57.0B-2.6%	$58.5B+17.9%	$49.6B+31.6%	$37.7B-21.9%	$48.3B+65.8%	$29.1B-20.0%	$36.4B+12.2%	$32.5B+32.9%	$24.4B-1.2%	$24.7B+1.2%	$24.4B+12.4%	$21.7B+21.6%	$17.9B-16.0%	$21.3B+12.2%	$19.0B
EPS (Basic)	N/A	$20.05+1.3%	$19.79+21.8%	$16.25+34.3%	$12.10-21.4%	$15.39+73.1%	$8.89-17.3%	$10.75+18.9%	$9.04+42.4%	$6.35+1.8%	$6.24+3.1%	$6.05+13.5%	$5.33+21.7%	$4.38-16.1%	$5.22+16.0%	$4.50
EPS (Diluted)	$23.35	$20.02+1.4%	$19.75+21.7%	$16.23+34.2%	$12.09-21.3%	$15.36+73.0%	$8.88-17.2%	$10.72+19.1%	$9.00+42.6%	$6.31+1.9%	$6.19+3.2%	$6.00+13.4%	$5.29+21.9%	$4.34-16.5%	$5.20+16.1%	$4.48
Diluted Shares (Avg)	N/A	2.78B-3.4%	2.88B-2.2%	2.94B-0.9%	2.97B-1.9%	3.03B-2.0%	3.09B-4.4%	3.23B-5.4%	3.41B-4.6%	3.58B-3.1%	3.69B-2.2%	3.77B-0.6%	3.80B-0.5%	3.81B-0.2%	3.82B-2.5%	3.92B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$57.3B+27.7%	$49.8B+10.0%	$45.8B+7.1%	$46.4B+8.8%	$44.9B-10.5%	$45.3B+8.1%	$42.8B+10.9%	$42.7B+7.0%
SG&A Expenses	$15.2B+10.6%	$15.3B+8.8%	$13.1B+5.2%	$13.6B+5.8%	$13.7B+5.8%	$14.1B+7.4%	$12.5B+5.3%	$12.8B+9.3%
Interest Expense	$25.1B+0.3%	$23.8B+1.0%	$23.8B-1.7%	$25.5B-5.7%	$25.0B-2.9%	$23.6B-3.2%	$24.2B+3.8%	$27.0B+23.7%
Income Tax	$6.4B+92.9%	$4.0B+5.8%	$4.1B+22.7%	$4.3B+6.6%	$3.3B-37.6%	$3.8B-2.8%	$3.4B+66.9%	$4.1B+13.9%
Net Income	$21.2B+41.2%	$16.5B+12.6%	$13.0B-7.5%	$14.4B+11.6%	$15.0B-17.4%	$14.6B+9.1%	$14.0B+50.0%	$12.9B-1.9%
EPS (Basic)	$7.71+46.9%	$5.95+17.1%	$4.64-3.7%	$5.08+16.0%	$5.25-14.4%	$5.08+14.2%	$4.82+58.0%	$4.38+1.2%
EPS (Diluted)	$7.70+46.9%	$5.94+17.2%	$4.64-3.5%	$5.07+16.0%	$5.24-14.4%	$5.07+14.2%	$4.81+57.7%	$4.37+0.9%
Diluted Shares (Avg)	2.69B-3.6%	2.72B-3.7%	N/A	2.77B-3.4%	2.79B-3.5%	2.82B-3.0%	N/A	2.87B-2.3%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

JPM Balance Sheet

JPM quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$4.4T+10.5%	$4.0T+3.3%	$3.9T+5.7%	$3.7T-2.1%	$3.7T+10.6%	$3.4T+26.0%	$2.7T+2.4%	$2.6T+3.5%	$2.5T+1.7%	$2.5T+5.9%	$2.4T-8.6%	$2.6T+6.5%	$2.4T+2.4%	$2.4T+4.1%	$2.3T
Cash & Equivalents	$343.3B-26.8%	$469.3B-24.8%	$624.2B+10.0%	$567.2B-23.4%	$740.8B+40.4%	$527.6B+100.1%	$263.6B-5.4%	$278.8B-35.4%	$431.3B+10.3%	$391.2B+8.1%	$361.7B	N/A	N/A	N/A	N/A
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A
Goodwill	$52.7B+0.3%	$52.6B-0.1%	$52.6B+1.9%	$51.7B+2.7%	$50.3B+2.2%	$49.2B+3.0%	$47.8B+0.7%	$47.5B-0.1%	$47.5B+0.5%	$47.3B-0.1%	$47.3B-0.7%	$47.6B-0.9%	$48.1B-0.2%	$48.2B0.0%	$48.2B
Total Liabilities	$4.1T+11.1%	$3.7T+3.1%	$3.5T+5.2%	$3.4T-2.2%	$3.4T+11.1%	$3.1T+28.0%	$2.4T+2.5%	$2.4T+3.9%	$2.3T+1.8%	$2.2T+6.3%	$2.1T-10.1%	$2.3T+6.2%	$2.2T+2.3%	$2.2T+3.5%	$2.1T
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$267.9B+7.6%	$249.0B-3.0%	$256.8B
Total Equity	$362.4B+5.1%	$344.8B+5.1%	$327.9B+12.2%	$292.3B-0.6%	$294.1B+5.3%	$279.4B+6.9%	$261.3B+1.9%	$256.5B+0.3%	$255.7B+0.6%	$254.2B+2.7%	$247.6B+6.8%	$231.7B+9.7%	$211.2B+3.5%	$204.1B+11.2%	$183.6B
Retained Earnings	$416.1B+10.6%	$376.2B+13.0%	$332.9B+12.3%	$296.5B+8.9%	$272.3B+14.9%	$237.0B+6.2%	$223.2B+12.1%	$199.2B+12.1%	$177.7B+9.4%	$162.4B+10.9%	$146.4B+12.7%	$130.0B+12.3%	$115.8B+11.1%	$104.2B+18.0%	$88.3B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$5.0T+10.2%	$4.9T+12.5%	$4.4T+10.5%	$4.6T+8.3%	$4.6T+9.9%	$4.4T+6.5%	$4.0T+3.3%	$4.2T+8.0%
Cash & Equivalents	$309.8B-26.3%	$312.1B-26.7%	$343.3B-26.8%	$303.4B-30.1%	$420.3B-20.8%	$425.9B-24.2%	$469.3B-24.8%	$434.3B-15.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$52.7B-0.1%	$52.7B+0.2%	$52.7B+0.3%	$52.7B0.0%	$52.7B+0.2%	$52.6B0.0%	$52.6B-0.1%	$52.7B+0.4%
Total Liabilities	$4.6T+10.6%	$4.5T+13.2%	$4.1T+11.1%	$4.2T+8.7%	$4.2T+10.3%	$4.0T+6.7%	$3.7T+3.1%	$3.9T+7.9%
Total Equity	$374.6B+5.0%	$364.0B+3.6%	$362.4B+5.1%	$360.2B+4.2%	$356.9B+4.8%	$351.4B+4.4%	$344.8B+5.1%	$345.8B+9.0%
Retained Earnings	$445.0B+12.0%	$428.2B+10.8%	$416.1B+10.6%	$407.4B+11.3%	$397.4B+11.3%	$386.6B+12.9%	$376.2B+13.0%	$366.0B+11.9%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

JPM Cash Flow Statement

JPM quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$162.5B	-$147.8B-251.8%	-$42.0B-423.8%	$13.0B-87.9%	$107.1B+37.2%	$78.1B+197.7%	-$79.9B-2052.8%	$4.1B-73.8%	$15.6B+244.2%	-$10.8B-149.5%	$21.9B-70.2%	$73.5B+100.8%	$36.6B-66.1%	$108.0B+330.5%	$25.1B-73.9%	$95.9B
Depreciation & Amortization	N/A	$8.8B+11.1%	$7.9B+5.7%	$7.5B+6.5%	$7.1B-11.1%	$7.9B-7.9%	$8.6B+2.9%	$8.4B+7.4%	$7.8B+26.1%	$6.2B+12.8%	$5.5B+10.9%	$4.9B+3.8%	$4.8B-10.3%	$5.3B+3.1%	$5.1B+20.9%	$4.3B
Stock-Based Compensation	N/A	$3.6B+3.1%	$3.5B+12.4%	$3.1B+11.6%	$2.8B-4.6%	$2.9B+19.5%	$2.5B+8.6%	$2.3B-2.8%	$2.3B+12.2%	$2.1B+6.7%	$1.9B-2.4%	$2.0B-9.3%	$2.2B-1.3%	$2.2B-12.8%	$2.5B-4.9%	$2.7B
Investing Cash Flow	-$185.8B	-$265.6B-62.5%	-$163.4B-341.6%	$67.6B+149.1%	-$137.8B-6.6%	-$129.3B+50.6%	-$261.9B-403.1%	-$52.1B+73.9%	-$199.4B-805.9%	$28.2B+131.7%	-$89.2B-183.4%	$107.0B+164.6%	-$165.6B-10.1%	-$150.5B-25.6%	-$119.8B+29.8%	-$170.8B
Financing Cash Flow	$248.1B	$269.5B+324.8%	$63.4B+348.1%	-$25.6B+79.7%	-$126.3B-145.7%	$276.0B-53.7%	$596.6B+1708.7%	$33.0B-3.4%	$34.2B+133.3%	$14.6B-85.1%	$98.3B+152.4%	-$187.5B-258.6%	$118.2B+317.4%	$28.3B-67.7%	$87.7B-18.6%	$107.7B
Dividends Paid	$17.3B	$16.6B+12.5%	$14.8B+9.8%	$13.5B-0.7%	$13.6B+5.5%	$12.9B+1.3%	$12.7B+2.8%	$12.3B+22.1%	$10.1B+12.4%	$9.0B+6.1%	$8.5B+7.7%	$7.9B+12.6%	$7.0B+15.4%	$6.1B+16.6%	$5.2B+33.4%	$3.9B
Share Buybacks	$31.7B	$31.6B+67.8%	$18.8B+91.7%	$9.8B+210.7%	$3.2B-82.8%	$18.4B+182.5%	$6.5B-72.8%	$24.0B+20.1%	$20.0B+29.7%	$15.4B+69.7%	$9.1B+61.7%	$5.6B	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$25.3B-185.6%	-$211.8B+15.9%	$119.7B-19.0%	-$45.2B+39.0%	$29.5B-23.2%	-$251.8B-63.4%	$147.8B+145.3%	-$74.1B-264.2%
Depreciation & Amortization	$2.3B+4.8%	$2.4B+16.5%	$2.3B+17.7%	$2.3B+15.4%	$2.2B+10.4%	$2.0B+1.3%	$2.0B-41.1%	$2.0B-2.6%
Stock-Based Compensation	$1.2B+21.7%	$1.2B+11.4%	N/A	$910.0M+7.2%	$959.0M+1.6%	$1.1B+12.3%	N/A	$849.0M+8.6%
Investing Cash Flow	$6.4B+103.7%	-$217.8B-84.4%	$46.9B+166.1%	-$21.3B+50.9%	-$173.1B-83.6%	-$118.1B-172.2%	$17.6B-77.9%	-$43.4B-144.0%
Financing Cash Flow	$18.8B-84.7%	$400.7B+26.0%	-$123.6B-6.8%	-$47.8B-544.6%	$122.8B+350.9%	$318.1B+125.3%	-$115.7B-222.3%	$10.7B+349.0%
Dividends Paid	$4.3B+3.3%	$4.4B+14.4%	$4.4B+14.5%	$4.2B+14.4%	$4.2B+11.3%	$3.8B+9.4%	$3.9B+12.6%	$3.7B+7.9%
Share Buybacks	$6.8B-9.6%	$8.3B+10.6%	$8.3B+92.1%	$8.3B+30.4%	$7.5B+40.7%	$7.5B+165.8%	$4.3B+89.1%	$6.4B+167.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

JPM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JPM quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	31.2%-1.7pp	33.0%+1.6pp	31.4%+2.1pp	29.3%-10.4pp	39.7%+15.4pp	24.3%-7.2pp	31.5%+1.6pp	29.8%+5.6pp	24.3%-1.3pp	25.6%-0.5pp	26.1%+3.3pp	22.9%+4.5pp	18.4%-3.6pp	21.9%+2.4pp	19.5%
Return on Equity	15.7%-1.2pp	17.0%+1.8pp	15.1%+2.2pp	12.9%-3.5pp	16.4%+6.0pp	10.4%-3.5pp	13.9%+1.3pp	12.7%+3.1pp	9.6%-0.2pp	9.7%-0.1pp	9.9%+0.5pp	9.4%+0.9pp	8.5%-2.0pp	10.4%+0.1pp	10.3%
Return on Assets	1.3%-0.2pp	1.5%+0.2pp	1.3%+0.3pp	1.0%-0.3pp	1.3%+0.4pp	0.9%-0.5pp	1.4%+0.1pp	1.2%+0.3pp	1.0%0.0pp	1.0%0.0pp	1.0%+0.2pp	0.9%+0.1pp	0.7%-0.2pp	0.9%+0.1pp	0.8%
Debt-to-Equity	11.21+0.6x	10.61-0.2x	10.82-0.7x	11.54-0.2x	11.73+0.6x	11.12+1.8x	9.28+0.1x	9.22+0.3x	8.91+0.1x	8.80+0.3x	8.50-1.6x	10.10+8.8x	1.270.0x	1.22-0.2x	1.40
Asset Turnover	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.030.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.04

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	36.9%+3.5pp	33.1%+0.8pp	28.3%-4.5pp	31.0%+0.8pp	33.4%-2.8pp	32.3%+0.3pp	32.8%+8.6pp	30.2%-2.7pp
Return on Equity	5.7%+1.4pp	4.5%+0.4pp	3.6%-0.5pp	4.0%+0.3pp	4.2%-1.1pp	4.2%+0.2pp	4.1%+1.2pp	3.7%-0.4pp
Return on Assets	0.4%+0.1pp	0.3%0.0pp	0.3%-0.1pp	0.3%0.0pp	0.3%-0.1pp	0.3%0.0pp	0.4%+0.1pp	0.3%0.0pp
Debt-to-Equity	12.39+0.6x	12.46+1.1x	11.21+0.6x	11.66+0.5x	11.75+0.6x	11.40+0.2x	10.61-0.2x	11.17-0.1x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
JPMorgan Chase & Co. JPM	FY2025	$182.4B	$57.0B	31.2%	$888.6B	51/100
Bank of America Corporation BAC	FY2025	$113.1B	$30.5B	27.0%	$379.8B	42/100
Wells Fargo & Co. WFC	FY2025	$83.7B	$21.3B	25.5%	$252.7B	35/100
HSBC Holdings plc HSBC	FY2025	$68.3B	$23.1B	33.9%	$318.0B	21/100
Citigroup Inc. C	FY2025	$85.2B	$14.3B	16.8%	$217.5B	26/100

Where JPMorgan Chase & Co. Ranks

Frequently Asked Questions

What is JPMorgan Chase & Co.'s annual revenue?

JPMorgan Chase & Co. (JPM) reported $182.4B in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is JPMorgan Chase & Co.'s revenue growing?

JPMorgan Chase & Co. (JPM) revenue grew by 2.8% year-over-year, from $177.6B to $182.4B in fiscal year 2025.

Is JPMorgan Chase & Co. profitable?

Yes, JPMorgan Chase & Co. (JPM) reported a net income of $57.0B in fiscal year 2025, with a net profit margin of 31.2%.

What is JPMorgan Chase & Co.'s net profit margin?

JPMorgan Chase & Co. (JPM) had a net profit margin of 31.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does JPMorgan Chase & Co. pay dividends?

Yes, JPMorgan Chase & Co. (JPM) paid $5.80 per share in dividends during fiscal year 2025.

What is JPMorgan Chase & Co.'s return on equity (ROE)?

JPMorgan Chase & Co. (JPM) has a return on equity of 15.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is JPMorgan Chase & Co.'s operating cash flow?

JPMorgan Chase & Co. (JPM) recorded an outflow of $147.8B in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are JPMorgan Chase & Co.'s total assets?

JPMorgan Chase & Co. (JPM) had $4.4T in total assets as of fiscal year 2025, including both current and long-term assets.

Does JPMorgan Chase & Co. buy back shares?

Yes, JPMorgan Chase & Co. (JPM) spent $31.6B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does JPMorgan Chase & Co. have outstanding?

JPMorgan Chase & Co. (JPM) had 2.70B shares outstanding as of fiscal year 2025.

What is JPMorgan Chase & Co.'s debt-to-equity ratio?

JPMorgan Chase & Co. (JPM) had a debt-to-equity ratio of 11.21 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is JPMorgan Chase & Co.'s return on assets (ROA)?

JPMorgan Chase & Co. (JPM) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is JPMorgan Chase & Co.'s P/E ratio?

JPMorgan Chase & Co. (JPM) trades at 13.7x earnings, its market capitalization divided by net income of $65.0B net income, trailing 12 months to June 30, 2026. The market capitalization is $888.6B as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is JPMorgan Chase & Co.'s price-to-sales ratio?

JPMorgan Chase & Co. (JPM) trades at 4.5x sales, its market capitalization divided by revenue of $199.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $888.6B as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is JPMorgan Chase & Co.'s Piotroski F-Score?

JPMorgan Chase & Co. (JPM) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are JPMorgan Chase & Co.'s earnings high quality?

For every $1 of reported earnings, JPMorgan Chase & Co. (JPM) used $2.59 of operating cash (-$147.8B OCF vs $57.0B net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is JPMorgan Chase & Co.?

JPMorgan Chase & Co. (JPM) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.